
Melissa Rohman
Journalist at Freelance
Freelance Writer at The New York Times
✨ Storyteller | Writer | Editor | Multimedia Producer ✨ News Writer at @NUFeinbergMed | More words in @nytimes, @healthimaging, @WashingtonExec
Articles
-
2 weeks ago |
medicalxpress.com | Melissa Rohman |Gaby Clark |Robert Egan
Northwestern Medicine investigators have discovered that a novel long noncoding RNA (lncRNA), which are usually 200 nucleotides longer than typical RNAs and are widely expressed in cells, could serve as a prognostic biomarker and therapeutic target for prostate cancer, according to a recent study published in Science Advances. Qi Cao, Ph.D., the Anthony J. Schaeffer, MD, Professor of Urology, and Rendong Yang, Ph.D., associate professor of Urology, were co-corresponding authors of the study.
-
3 weeks ago |
phys.org | Melissa Rohman
Scientists led by Karla Satchell, Ph.D., the Anne Stewart Youmans Professor of Microbiology at Northwestern University, have discovered previously unknown molecular mechanisms that help a type of food-borne bacteria recognize host cells and initiate infection on the cell surface, according to a recent study published in Science Advances.
-
1 month ago |
medicalxpress.com | Melissa Rohman
Northwestern Medicine investigators have discovered new intracellular mechanisms that help specialized immune cells adapt and respond to disease and acute inflammation, findings that may inform the development of targeted therapies for cancer and tissue injury, according to a recent study published in the Journal of Clinical Investigation.
-
1 month ago |
phys.org | Melissa Rohman
Northwestern Medicine investigators have developed first-of-its-kind eyedrops that use synthetic nanoparticles to help the eye regenerate cells that have been damaged by mustard keratopathy, or exposure to mustard gas, and other inflammatory eye diseases, detailed in a recent study published in the journal npj Regenerative Medicine.
-
1 month ago |
medicalxpress.com | Melissa Rohman
Screening for common genetic variants in addition to rare genetic variants can help improve patient risk stratification for heart failure, according to a recent study published in Nature Genetics led by investigators at Northwestern University Feinberg School of Medicine and the Perelman School of Medicine at the University of Pennsylvania. "Much of the focus, at least on the clinical side, has been looking at rare genetic variants and testing for them and determining your heart failure risk.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 313
- Tweets
- 839
- DMs Open
- No

RT @NorthwesternU: Got data? A new breastfeeding device measures babies' milk intake in real time 👶 A team of engineers, neonatologists an…

RT @NUFeinbergMed: Northwestern Medicine investigators have discovered how disruptions in #CircadianRhythm in our muscles, combined with po…

RT @NUFeinbergMed: Northwestern Medicine scientists have revealed the mechanisms behind cellular #adhesion and #repair, per @JCellBiol. htt…